Sign In
Buy AJINY
$27.98
+0 (+0%)
At Close: Jun 02, 2026
Ajinomoto Q4 Earnings: The Good And The Bad
11:07am, Friday, 15'th May 2026
I am initiating on Ajinomoto with a 'Hold' rating, after evaluating its results and outlook. The company's FY2025 EPS beat the consensus forecast, but its FY26 business profit guidance implies a subst
Analyzing J. M. Smucker (NYSE:SJM) and Ajinomoto (OTCMKTS:AJINY)
03:07am, Sunday, 26'th Apr 2026
J. M. Smucker (NYSE: SJM - Get Free Report) and Ajinomoto (OTCMKTS:AJINY - Get Free Report) are both large-cap consumer staples companies, but which is the superior investment? We will compare the two
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
08:00am, Thursday, 16'th Apr 2026
Piramal Pharma Solutions is a global leader in antibody-drug conjugate (ADC) development and manufacturing, leveraging over 20 years of specialized experience to support partners from early-stage to c
Is MSG Maker Ajinomoto Sitting on an AI Goldmine? This Investor Thinks So
02:57am, Friday, 10'th Apr 2026
An activist investor has built a stake in a Japanese company it says has a lucrative monopoly on a material vital to artificial-intelligence infrastructure.
Critical Contrast: Ajinomoto (OTCMKTS:AJINY) vs. J. M. Smucker (NYSE:SJM)
02:02am, Monday, 06'th Apr 2026
J. M. Smucker (NYSE: SJM - Get Free Report) and Ajinomoto (OTCMKTS:AJINY - Get Free Report) are both large-cap consumer staples companies, but which is the better stock? We will contrast the two busin
Palliser Capital Publishes Value Enhancement Plan for Ajinomoto
03:00am, Tuesday, 31'st Mar 2026
LONDON--(BUSINESS WIRE)--Palliser Capital (“Palliser”), a top 25 shareholder of Ajinomoto Co., Inc. (“Ajinomoto” or the “Company”), today published a comprehensive presentation outlining t
Ajinomoto Co., Inc. (AJINY) Q3 2026 Earnings Call Transcript
06:54am, Thursday, 05'th Feb 2026
Ajinomoto Co., Inc. (AJINY) Q3 2026 Earnings Call Transcript
Ajinomoto Co., Inc. (AJINY) Q2 2026 Earnings Call Transcript
11:26am, Thursday, 06'th Nov 2025
Ajinomoto Co., Inc. (OTCPK:AJINY) Q2 2026 Earnings Call November 6, 2025 4:00 AM EST Company Participants Masataka Kaji - General Manager of IR Group - Global Finance Department Shigeo Nakamura - Pres
Ajinomoto Co., Inc. - Special Call
02:36am, Tuesday, 14'th Oct 2025
Ajinomoto Co., Inc. - Special Call Company Participants Masataka Kaji Shigeo Nakamura - President, CEO, Representative Executive Officer & Director Naoko Yamamoto - Executive Officer Normando Filho Na
Ajinomoto Co., Inc. (AJINY) Q1 2026 Earnings Call Transcript
01:14pm, Monday, 04'th Aug 2025
Ajinomoto Co., Inc. (OTCPK:AJINY) Q1 2026 Earnings Conference Call August 4, 2025 4:00 AM ET Company Participants Masataka Kaji - Former General Manager of IR Group, Global Finance Department Conferen
Ajinomoto Co., Inc. (AJINY) Q4 2025 Earnings Call Transcript
02:36pm, Saturday, 10'th May 2025
Ajinomoto Co., Inc. (OTCPK:AJINY) Q4 2025 Results Conference Call May 8, 2025 5:00 AM ET Company Participants Masataka Kaji - Investor Relations Department Shigeo Nakamura - President, CEO & Represent
Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Phenylalanine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been added to
Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Alanyl-L-Glutamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been add
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
03:00am, Thursday, 24'th Apr 2025
PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquirin
Ajinomoto Co., Inc. (AJINY) Q2 2024 Earnings Call Transcript
02:22pm, Saturday, 09'th Nov 2024
Ajinomoto Co., Inc. (OTCPK:AJINY) Q2 2024 Earnings Conference Call November 7, 2024 4:00 AM ET Company Participants Masataka Kaji - Investor Relations Department Taro Fujie - Representative Executive
